Some people are affected by both gout and type 2 diabetes; in this situation, blocking the IL-1 system appears to be highly efficient at lowering fasting blood glucose and HbA1c and improving gout, as reported in case reports and anecdotally [124]. Here, IL1A is linked to type 2 diabetes mellitus.